EFFICACY OF PIRFENIDONE ON DYSPNEA IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): RESULTS FROM A POST HOC RESPONDER ANALYSIS

被引：0
|
作者：
Glassberg, Marilyn K.
Thavarajah, Krishna
Collins, Bridget F.
Gupta, Sachin
Trzaskoma, Benjamin
Kirchgaessler, Klaus-Uwe
Devine, Jacob
Raghu, Ganesh
机构：
来源：
CHEST | 2022年 / 162卷 / 04期
关键词：
D O I：
10.1016/j.chest.2022.08.996
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1246A / 1247A
页数：2
相关论文
共 50 条
  • [1] Sildenafil Added to Pirfenidone in Patients with Advanced Idiopathic Pulmonary Fibrosis (IPF) and Risk of Pulmonary Hypertension (PH): Results of a Responder Analysis
    Harari, S.
    Nathan, S. D.
    Behr, J.
    Wuyts, W. A.
    Kirchgaessler, K.
    Bengus, M.
    Gilberg, F.
    Wells, A. U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [2] Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF)
    Takaiwa, Takuya
    Tachibana, Hiromasa
    Arita, Machiko
    Ishida, Tadashi
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [3] Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF)
    Takaiwa, Takuya
    Tachibana, Hiromasa
    Arita, Machiko
    Ishida, Tadashi
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [4] EFFICACY OF PIRFENIDONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Inagaki, Ai
    Tsutsumi, Takeo
    Kuriyama, Sachiko
    Nagaoka, Tetsutaro
    Sekiya, Mitsuaki
    Morio, Yoshiteru
    Takahashi, Kazuhisa
    RESPIROLOGY, 2013, 18 : 135 - 135
  • [5] Evaluation of Dyspnea Questionnaires in Patients with Idiopathic Pulmonary Fibrosis (IPF).
    Mendoza, Onofre Moran
    Aldaheri, Sharina
    Alyami, Sami
    Kish, Maxine
    Davison, Sean
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [6] Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF)
    Balestro, Elisabetta
    Turato, Graziella
    Biondini, Davide
    Pavanello, Sofia
    Fraccaro, Alessia
    Rigobello, Chiara
    Bazzan, Erica
    Campisi, Manuela
    Baraldo, Simonetta
    Cosio, Manuel
    Saetta, Marina
    Spagnolo, Paolo
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [7] Mechanisms of treatment response to pirfenidone of idiopathic pulmonary fibrosis (IPF) patients
    Ronan, Nicola
    Khan, Kashif A.
    Subramaniam, Abirami
    McCarthy, Yvonne
    Burke, Louise
    Chelliah, A.
    Plant, Barry J.
    Henry, Michael T.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [8] POST HOC ANALYSIS OF CLINICAL CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) BY PULMONARY VASCULAR PHENOTYPE FROM CAPACITY
    Saggar, Rajan
    Nathan, Steven D.
    Chakinala, Murali M.
    Joshua, Jisha K.
    Gupta, Sachin
    Trzaskoma, Benjamin
    Lancaster, Lisa H.
    CHEST, 2022, 162 (04) : 1248A - 1250A
  • [9] EFFECT OF PIRFENIDONE ON EXERCISE CAPACITY AND DYSPNEA IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) AND MORE ADVANCED LUNG FUNCTION IMPAIRMENT
    Nathan, Steven
    Bradley, Sarah
    Costabel, Ulrich
    Albera, Carlo
    Behr, Juergen
    Wuyts, Wim
    Kirchgaessler, Klaus-Uwe
    Stauffer, John
    Morgenthien, Elizabeth
    Yang, Ming
    Limb, Susan
    Noble, Paul
    CHEST, 2018, 154 (04) : 432A - 433A
  • [10] CLINICAL EFFICACY OF PIRFENIDONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Yamauchi, H.
    Bando, M.
    Sata, M.
    Nakasone, E.
    Mizushina, Y.
    Suzuki, E.
    Mato, N.
    Nakaya, T.
    Yamasawa, H.
    Sugiyama, Y.
    RESPIROLOGY, 2011, 16 : 318 - 319
12345